Molecular mechanisms underlying cardiac sodium channelopathy
Molecular mechanisms underlying cardiac sodium channelopathy
批准号:
9974589
负责人:
Masayuki Yazawa
金额:
$39.66万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-01 至 2022-06-30
关键词:
Action PotentialsAddressAffectArrhythmiaBiological AssayBiomedical EngineeringCalciumCalcium ChannelCardiacCardiac MyocytesCellsChemicalsConsensusCouplingCyclin-Dependent Kinase 5DNA Sequence AlterationDiseaseDisease modelElectrocardiogramElectrophysiology (science)EmbryoEngineeringFamilial Hypertrophic CardiomyopathyFunctional disorderFutureGenesGoalsHeartHumanHyperactive behaviorHypertrophic CardiomyopathyIn VitroInvestigationKnockout MiceLidocaineLong QT SyndromeMeasuresMediatingMexiletineMicrofilamentsModelingMolecularMusMuscle CellsMutagenesisMutant Strains MiceMutationMyocardial dysfunctionMyosin Heavy ChainsOutcomePatientsPhenotypePhosphorylation SitePhosphotransferasesPhysiologicalPlayPropertyProteinsRecombinantsRegulationRiskRodentRodent ModelRoleSamplingSkinSodiumSodium ChannelSudden DeathSystemTechniquesTechnologyTestingTherapeuticTimeUnited StatesVentricularVisiondesignexperimental studyheart functionhuman modelin vivoinduced pluripotent stem cellinhibitor/antagonistinnovationinsightmouse modelmutantnoveloverexpressionranolazinesmall hairpin RNAstem cell modelvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
The cardiac voltage-gated sodium channel, NaV1.5, plays an important role in cardiac function. Genetic
mutations in NaV1.5 are known to be associated with various cardiac arrhythmias including long QT syndrome.
Our preliminary results suggested that NaV1.5 channel is regulated by cyclin-dependent kinase 5 (CDK5) and
that CDK5 and NaV1.5 channel are involved in cardiac arrhythmias caused by genetic mutations in the
CACNA1C calcium channel and MYH7 myofilament genes. The primary goal of this study is to unveil the
molecular mechanisms of cardiac NaV1.5 channel regulation and to elucidate the pathophysiological
mechanisms underlying cardiac arrhythmias associated with sodium channelopathy. Aim 1 is to examine how
CDK5 regulates NaV1.5 channels using human and mouse models with electrophysiological recordings. Aim 2
is to elucidate how cardiac sodium channel dysfunction results from the cardiac calcium channel mutants in
long QT syndrome type 8. Aim 3 is to test the hypothesis that CDK5 and NaV1.5 abnormalities are involved in
familial hypertrophic cardiomyopathy and arrhythmias that are caused by a familial MYH7 mutation. The
approaches of our study would provide new insights into the molecular basis of cardiac sodium channel
regulation and the pathophysiological mechanisms underlying cardiac arrhythmias with sodium channelopathy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Therapeutics for Timothy Syndrome and Related Cardiac Channelopathy
-
批准号:10911506
-
项目类别:
-
资助金额:$70.94万
-
财政年份:2023
-
负责人:Masayuki Yazawa
-
依托单位:
Novel Therapeutics for Long QT Syndrome
-
批准号:10897465
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2022
-
负责人:Masayuki Yazawa
-
依托单位:
Novel Therapeutics for Long QT Syndrome
-
批准号:10705357
-
项目类别:
-
资助金额:$24.55万
-
财政年份:2022
-
负责人:Masayuki Yazawa
-
依托单位:
Molecular mechanisms underlying cardiac sodium channelopathy
-
批准号:10199772
-
项目类别:
-
资助金额:$39.76万
-
财政年份:2017
-
负责人:Masayuki Yazawa
-
依托单位:
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells
-
批准号:8399063
-
项目类别:
-
资助金额:$8.63万
-
财政年份:2012
-
负责人:Masayuki Yazawa
-
依托单位:
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells
-
批准号:8811467
-
项目类别:
-
资助金额:$24.4万
-
财政年份:2012
-
负责人:Masayuki Yazawa
-
依托单位:
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells
-
批准号:8626438
-
项目类别:
-
资助金额:$24.4万
-
财政年份:2012
-
负责人:Masayuki Yazawa
-
依托单位:
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells
-
批准号:8598272
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2012
-
负责人:Masayuki Yazawa
-
依托单位:
Model of Timothy Syndrome to Screen Drugs with Induced Pluripotent Stem Cells
-
批准号:8226405
-
项目类别:
-
资助金额:$8.63万
-
财政年份:2012
-
负责人:Masayuki Yazawa
-
依托单位:
海外基金